Skip to content
Wednesday, November 11, 2026
UpdateNetPlus UK

The Zimbabwean Government Rejects ‘Lopsided’ US Healthcare Assistance Deal Because of Data Apprehensions

Health aid illustration
The proposed US funding would have supported initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has turned down a major US healthcare agreement valued at $367m (£272m) spanning five years due to the United States' insistence on sensitive information.

This rejection came to light after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "lopsided".

A government representative has since clarified that the US was demanding access to biological samples for research and profit while was unwilling to share the benefits from future treatments.

"We must now begin the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for further dialogue to reach a agreement agreeable to all parties so the country's vital HIV programme can proceed.

Broader Implications

Zimbabwe's decision comes after a similar situation in Kenya, where a court suspended a related deal with the US after legal challenges were filed about the security of Kenyans' medical information.

Since resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

The agency had managed aid for the US government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral agreements to enhance transparency and accountability.

Based on reports, 16 African countries have so far signed these new agreements, constituting more than $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through American-funded initiatives," Tremont commented.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no equivalent guarantee of access to any medical innovations – like new medicines or tests – that might be developed from that provided information," he stated.

"In essence, our nation would provide the raw materials for scientific discovery with no assurance that the end products would be available to our population if a new pandemic emerge."

National Interest and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks already established via the global health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.

"This system is designed to ensure that when a nation contributes its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."

The government's concerns over the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We are open to further discussions with our US partners on how future co-operation could be arranged in a way that honours the independence and dignity of both nations."

Health Experts Reaction

A leading public health body expressed it acknowledged the official position, but suggested that talks need to persist given that a large portion of the country's Aids initiatives depended on external financing.

"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," the group said.

The halted deal highlights the continuing challenges between receiving much-needed foreign assistance and protecting a country's data in an ever more data-driven world.

By

Kristin Carter

A tech journalist and digital strategist with over a decade of experience covering UK tech innovations and cybersecurity trends.

UpdateNetPlus UK

Type to search articles.